Pharmafile Logo

Launch excellence

- PMLiVE

In the April edition of PME, Cheryl Harrison Doyle, Global Asset Strategy Director at Lucid Group discusses the need to take a more considered, outcomes-led approach when launching new medicines today.

With a rapidly changing clinical, economic and regulatory environment, the launch of new products has catapulted the pharmaceutical industry into greater complexity and pressure than ever before. Historically, new asset launches have been a tale of two halves: a hit or miss. Between 2009 and 2017, 40% of worldwide drug launches failed to meet their 2-year sales forecasts, according to McKinsey & Company1. Taking into consideration the evolving environment, there has never been a greater need for new models to navigate the path of an asset to market.

Over the past 15 years, our clients have regularly come to us to help them execute their launch plans. Often the ask is around launch readiness and activation, with a focus on tactical execution. In this article, we discuss the need to get ahead of tactical planning and demonstrate the role of ‘pre-launch asset preparedness’, to ensure we maximise the potential of specialised medicines in this highly complex environment.

You can read the full article online here or download it so you can read it later here.

If you’re planning a launch and looking for some advice, get in touch! We’re hosting free launch-strategy clinics throughout May and June. Contact Cheryl Harrison Doyle or Clare Reynolds for more details.

cheryl.harrisondoyle@wearelucidgroup.com
07818 568882

clare.reynolds@wearelucidgroup.com
07501 989799

This content was provided by Lucid Group Communications Limited

Company Details

 Latest Content from  Lucid Group Communications Limited 

Perfect Timing?

Timing is often the reason for embracing a new approach "this is ideal timing for our strategic planning", yet can also be a major barrier for doing more of the same...

Lucid Group Achieve UK’s Highest Award for Business Success

Lucid Group have been chosen to receive a Queen’s Award for Enterprise in International Trade. This award is widely regarded as the UK’s highest accolade for business success and they...

The driving force behind Momentum Strategy

An internet search on what makes a business successful delivers countless promises to reveal the secrets behind sustained growth. The strategies of well-known companies provide valuable case studies that have...

Lucid Partners US changes its name to Lighthouse Medical Communications US

With immediate effect Lucid Partners US will change its name to Lighthouse Medical Communications US.The demand for the Lucid Group services in the US has grown rapidly, and by creating a...

Bring some #LucidLife to your medical education programmes

Meet Madeleine, an Account Director.Madeleine understands the importance of improving patient outcomes and has played a pivotal part in developing many of our award-winning behaviour-change programmes.Our people are our biggest...

Lucid Group gains further momentum with launch of new Strategic Consultancy

Lucid Group has made an exciting company expansion with the launch of the new Lucid Strategic Consultancy and the appointment of Duncan Ferguson as MD.Duncan Ferguson is highly qualified for...

Cheers to 10 years!

Lucid Group celebrate their 10th birthday in style

A view from within #LucidLife

As we celebrate our 10 year anniversary, Joanne shares her #LucidLife journey